المصدر: Prospective Observational Study With Retrospective Part to Evaluate Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Moderate-to-severe Plaque Psoriasis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06142357Test

المصدر: Moderate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world Setting: a Monocentric, Retrospective Study

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05787236Test

المصدر: 2 Years Prospective Study to Collect Real-life Data On the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial spondyloarthriTis (PROMPT)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05155098Test

المصدر: A Double Blind, Randomized, Placebo Controlled, Multicenter, Dose Finding Study of Oral AEB071 Assessing Psoriasis Area and Severity Index (PASI) Response and a Function of Dose and Treatment Duration (Primary Outcome) in Patients With Plaque Psoriasis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00885196Test

Other URLs: https://www.novctrd.com/ctrdweb/trialresult/trialresults/pdf?trialResultId=6743Test

المصدر: An Open-label, Single Sequence Crossover, Study Investigating the Influence of Secukinumab Treatment on the Pharmacokinetics of Midazolam as a CYP3A4 Substrate in Patients With Moderate to Severe Plaque Psoriasis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02607774Test

Other URLs: https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=203Test
https://www.novctrd.com/ctrdweb/trialresult/trialresults/pdf?trialResultId=16935Test